Mediation between Bayer and plaintiffs in the United States aims to clarify all justified claims related to Roundup herbicide both at the national and state level, mediator Ken Feinberg told a German magazine.
“The mediation is going slowly but steadily,” Wirtschaftswoche on Wednesday quoted Feinberg as saying.
Bayer is trying to reach a settlement after earlier court rulings against it. The German drugs and pesticides maker, which acquired Roundup and other glyphosate-based weed killers as part of its $63 billion takeover of Monsanto last year, faces potentially heavy litigation costs as plaintiffs claim Roundup causes cancer, something Bayer disputes.
(Reporting by Riham Alkousaa Editing by Michelle Martin)
Topics Claims
Was this article valuable?
Here are more articles you may enjoy.
Farmers Insurance Plans Historic, Rapid Expansion of Agency Force 
More Insurance M&A Deals on the Horizon? 
A Little Behind Schedule, But Execs Say Sypher Insurance is on Track for May Debut 
Tennessee Approves Smallest Drop in Workers’ Compensation Costs in Years 
